Yuan C. Weng
Quebec, QC G1J2G3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Virus-mediated delivery of single-chain antibody targeting TDP-43 protects against neuropathology, cognitive impairment and motor deficit caused by chronic cerebral hypoperfusion.
Journal: Experimental neurology
Published: October 11, 2024
Targeting SRSF3 restores immune mRNA translation in microglia/macrophages following cerebral ischemia.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 15, 2023
Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: January 22, 2021
Glucosamine-mediated immunomodulation after stroke is sexually dimorphic.
Journal: Brain, behavior, & immunity - health
Published: December 06, 2019
Age-related deregulation of TDP-43 after stroke enhances NF-κB-mediated inflammation and neuronal damage.
Journal: Journal of neuroinflammation
Published: July 31, 2018
Estrogen receptors alpha mediates postischemic inflammation in chronically estrogen-deprived mice.
Journal: Neurobiology of aging
Published: July 02, 2015
Brain-derived neurotrophic factor promotes vasculature-associated migration of neuronal precursors toward the ischemic striatum.
Journal: PloS one
Published: September 19, 2012
Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: July 28, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026